SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001827
Filing Date
2022-05-23
Accepted
2022-05-23 16:31:09
Documents
52
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eucr-20220331x10q.htm   iXBRL 10-Q 712584
2 EX-31.1 eucr-20220331xex31d1.htm EX-31.1 12650
3 EX-31.2 eucr-20220331xex31d2.htm EX-31.2 11458
4 EX-32.1 eucr-20220331xex32d1.htm EX-32.1 7991
5 EX-32.2 eucr-20220331xex32d2.htm EX-32.2 7983
  Complete submission text file 0001410578-22-001827.txt   3747069

Data Files

Seq Description Document Type Size
6 EX-101.SCH eucr-20220331.xsd EX-101.SCH 38927
7 EX-101.CAL eucr-20220331_cal.xml EX-101.CAL 19108
8 EX-101.DEF eucr-20220331_def.xml EX-101.DEF 136122
9 EX-101.LAB eucr-20220331_lab.xml EX-101.LAB 283323
10 EX-101.PRE eucr-20220331_pre.xml EX-101.PRE 223029
46 EXTRACTED XBRL INSTANCE DOCUMENT eucr-20220331x10q_htm.xml XML 556630
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Filer) CIK: 0001822929 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 10-Q | Act: 34 | File No.: 001-39650 | Film No.: 22952141
SIC: 6770 Blank Checks